Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients

American Journal of Clinical Pathology

Volumn 140, Issue 3, 2013, Pages 403-409

  Buyse, Sophie ^a   Roque Afonso, Anne Marie ^a,b,c   Vaghefi, Parissa ^a   Gigou, Michèle ^b,c   Dussaix, Elisabeth ^a,b,c   Duclos Vallée, Jean Charles ^a,b,c   Samuel, Didier ^a,b,c   Guettier, Catherine ^a,b,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Graft dysfunction; Graft hepatitis; Human herpesvirus 6; Liver transplantation

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VALACICLOVIR; VALGANCICLOVIR;

ACUTE HEPATITIS; ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT DYSFUNCTION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER NECROSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS LOAD;

GRAFT DYSFUNCTION; GRAFT HEPATITIS; HUMAN HERPESVIRUS 6; LIVER TRANSPLANTATION;

ADOLESCENT; ADULT; DNA, VIRAL; FEMALE; HEPATITIS; HERPESVIRUS 6, HUMAN; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ROSEOLOVIRUS INFECTIONS; VIRAL LOAD;

EID: 84882779716     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP0FWI2XAHECBJ     Document Type: Article

References (29)

1. Abdel Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009;15:2561-2569.
2. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005;18:217-245.
3. Chevret L, Boutolleau D, Halimi-Idri N, et al. Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure. J Med Virol. 2008;80:1051-1057.
4. Liatsos C, Mehta AB, Potter M, et al. The hepatologist in the haematologists' camp. Br J Haematol. 2001;113:567-578.
5. Ward KN. Human herpesviruses-6 and -7 infections. Curr Opin Infect Dis. 2005;18:247-252.
6. Cacheux W, Carbonell N, Rosmorduc O, et al. HHV-6- related acute liver failure in two immunocompetent adults: favourable outcome after liver transplantation and/or ganciclovir therapy. J Intern Med. 2005;258:573-578.
7. Ohashi M, Yoshikawa T, Asonuma K, et al. Human herpesvirus 6 fulminant hepatic failure treated by living donor liver transplantation. Pediatr Int. 2004;46:730-732.
8. Takikawa T, Hayashibara H, Harada Y, et al. Liver dysfunction, anaemia, and granulocytopenia after exanthema subitum. Lancet. 1992;340:1288-1289.
9. Vinnard C, Barton T, Jerud E, et al. A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transpl. 2009;15:1242-1246.
10. Ogata MK, Jun-ichi, SF. Human herpesvirus-6 infections and infection-preventive measures in transplant recipients. Future Virol. 2008;3:567-578.
11. Lautenschlager I, Hockerstedt K, Linnavuori K, et al. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis. 1998;26:702-707.
12. Loginov R, Harma M, Halme L, et al. HHV-6 DNA in peripheral blood mononuclear cells after liver transplantation. J Clin Virol. 2006;37(suppl 1):S76-S81.
13. Schlitt HJ, Shi L. Human herpesvirus-6 and liver transplantation. J Hepatol. 2002;37:681-683.
14. Yoshikawa T, Ihira M, Suzuki K, et al. Human herpesvirus 6 infection after living related liver transplantation. J Med Virol. 2000;62:52-59.
15. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, et al. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods. 2002;100:27-35.
16. Sobesky R, Feray C, Rimlinger F, et al. Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology. 2007;46:1704-1712.
17. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289-293.
18. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000;31:792-799.
19. Lautenschlager I, Linnavuori K, Hockerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation. 2000;69:2561-2566.
20. Rogers J, Rohal S, Carrigan DR, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation. 2000;69:2566-2573.
21. Humar A, Kumar D, Caliendo AM, et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation. 2002;73:599-604.
22. Ozaki Y, Tajiri H, Tanaka-Taya K, et al. Frequent detection of the human herpesvirus 6-specific genomes in the livers of children with various liver diseases. J Clin Microbiol. 2001;39:2173-2177.
23. Ishikawa K, Hasegawa K, Naritomi T, et al. Prevalence of Herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J Gastroenterol. 2002;37:523-530.
24. Harma M, Loginov R, Piiparinen H, et al. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc. 2005;37:1230-1232.
25. Galarraga MC, Gomez E, de Ona M, et al. Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients. Transplant Proc. 2005;37:2124-2126.
26. Pischke S, Gosling J, Engelmann I, et al. High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis. J Hepatol. 2012;56:1063-1069.
27. Lautenschlager I, Lappalainen M, Linnavuori K, et al. CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients. J Clin Virol. 2002;25(suppl 2):S57-S61.
28. Dockrell DH, Mendez JC, Jones M, et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation. 1999;67:399-403.
29. de Pagter PJ, Schuurman R, Meijer E, et al. Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. J Clin Virol. 2008;43:361-366.